Loading company…
Medra automates laboratory experiments using robotics and AI.
Medra develops the Continuous Science Platform, which combines robotics and AI to automate laboratory experiments. It serves academic institutions, biotechnology firms, and pharmaceutical companies. In December 2025, it raised USD 52 million in Series A funding led by Human Capital, with new and returning investors participating, to scale its platform and expand robotics and AI for drug discovery.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in